Aciclovir or acyclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C8H11N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X4HES1O11F, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)- but generally known as aciclovir, which bears US NIH Compound Identifier 2022. Aciclovir, also known as acyclovir, most often comes in forms natrium and sodium. European Medicines Agency schedules Aciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05235MIG. The term ACICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules aciclovir in its Anatomical Therapeutic Chemical (ATC) Classification. ACICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Aciclovir or acyclovir bears US NLM identifiers UMLS ID C0001367 and NCI Concept Code C205. SMILES: O(CN1C2[NH]C(NC(=O)C2NC1)N)CCO.